TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,686,973 | -52.6% | 201,791 | +40.9% | 0.01% | -50.0% |
| Q2 2023 | $3,556,815 | +85.6% | 143,189 | +12.4% | 0.01% | +66.7% |
| Q1 2023 | $1,915,991 | +17.0% | 127,393 | -8.0% | 0.01% | +20.0% |
| Q4 2022 | $1,637,390 | +13.4% | 138,410 | -43.2% | 0.01% | 0.0% |
| Q3 2022 | $1,444,000 | +19.4% | 243,874 | -14.3% | 0.01% | +66.7% |
| Q2 2022 | $1,209,000 | -42.1% | 284,558 | +29.5% | 0.00% | -25.0% |
| Q1 2022 | $2,089,000 | -32.9% | 219,700 | +34.1% | 0.00% | -33.3% |
| Q4 2021 | $3,112,000 | -42.9% | 163,800 | 0.0% | 0.01% | -45.5% |
| Q3 2021 | $5,451,000 | -19.0% | 163,800 | -5.6% | 0.01% | -21.4% |
| Q2 2021 | $6,730,000 | -18.2% | 173,500 | +1.6% | 0.01% | -22.2% |
| Q1 2021 | $8,228,000 | -2.7% | 170,700 | +5.0% | 0.02% | -10.0% |
| Q4 2020 | $8,453,000 | +88.7% | 162,500 | -2.9% | 0.02% | +81.8% |
| Q3 2020 | $4,480,000 | +45.2% | 167,400 | +5.7% | 0.01% | +22.2% |
| Q2 2020 | $3,086,000 | +135.9% | 158,400 | +19.2% | 0.01% | +125.0% |
| Q1 2020 | $1,308,000 | -0.1% | 132,900 | +12.7% | 0.00% | +33.3% |
| Q4 2019 | $1,309,000 | +97.7% | 117,900 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $662,000 | -10.8% | 117,900 | +37.4% | 0.00% | 0.0% |
| Q2 2019 | $742,000 | +9.9% | 85,800 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $675,000 | +153.8% | 83,900 | +29.5% | 0.00% | +100.0% |
| Q4 2018 | $266,000 | -21.3% | 64,800 | +7.5% | 0.00% | 0.0% |
| Q3 2018 | $338,000 | -57.4% | 60,300 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $793,000 | +36.3% | 60,300 | +47.1% | 0.00% | 0.0% |
| Q1 2018 | $582,000 | +73.2% | 41,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $336,000 | -30.9% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $486,000 | +18.0% | 41,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $412,000 | – | 41,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |